Trident Lifeline Ltd

Media coverage

• Trident Lifeline Limited featured in India Pharma Outlook magazine for growth and capabilities.
• Article highlights the company's journey, strengths and strategic initiatives.
• Digital edition link provided.

Award recognition

• Trident Lifeline received the 'Fastest Growing SMEs' award at the Gujarat Top 50 SME Awards.
• Award presented on 20 August 2026 at DoubleTree by Hilton, Ahmedabad.
• Selected from 1,524 nominations across Gujarat after multi-stage evaluation and jury.
• Recognition reinforces growth momentum and long-term value creation for stakeholders.

Meeting Details

• Date: 20 August 2026; One-on-One; Physical; Surat.
• Purpose: discuss publicly available information; UPSI not discussed.

Participants

• Company: Managing Director.
• Investors: Haitong Securities; Latin Manharlal Securities.

Meeting Details

• Date: 20 August 2026; One-on-One meeting; Physical.

Participants

• Investors: Yashika Pancholi (Haitong Securities); Bhavin Shah and Nirav Asher (Latin Manharlal Securities).

Purpose

• Purpose: discussion based on publicly available information; no UPSI discussed.

Award update

• Selected for the 'FASTEST GROWING SMES' award at the inaugural Top 50 SME Awards, Gujarat.
• Award to be presented at DoubleTree by Hilton, Ahmedabad, on 20 August 2026.
• No financial implications disclosed.

Resolutions and outcomes

• Purpose: Special resolutions to appoint independent directors and migrate listing.
• Resolution 1: Appoint Smita Davda as Non-Executive Independent Director for 5 years; passed (8,386,300 in favour).
• Resolution 2: Appoint Sachin Bhandari as Non-Executive Independent Director for 5 years; passed (8,386,300 in favour).
• Resolution 3: Approve migration to BSE/NSE Main Boards; promoter group participated; non-promoter votes meet two-times requirement.

Dematerialisation status

• Processing of dematerialisation requests completed; accepted or rejected by depositories.
• Dematerialised securities have been listed on exchanges where earlier issues are listed.
• Certificates received for dematerialisation were mutilated and cancelled; depository substituted as registered owner within timelines.

Board appointments

• Ms. Smita Kiran Davda appointed Additional Non-Executive Independent Director effective June 13, 2026.
• Her term is five years, subject to shareholder approval within three months or at the ensuing general meeting.
• She is a Fellow Chartered Accountant with experience in banking, finance, risk management, and governance.
• She is not related to any board director and is not debarred from holding directorship.
• Mr. Sachin Bhandari appointed Additional Non-Executive Independent Director effective June 13, 2026, or DIN date, whichever is later.
• His term is five consecutive years, subject to shareholder approval within three months or at the ensuing general meeting.
• He has pharmaceutical industry experience in quality systems, regulatory compliance, digital transformation, and risk management.
• He is not related to any board director and is not debarred from holding directorship.

Scrutinizer appointment

• M/s. Mittal V Kothari & Associates appointed as scrutinizer for postal ballot remote e-voting.
• Appointment is to conduct the postal ballot in a fair and transparent manner.

Remote e-voting agency

• National Securities Depository Limited appointed as remote e-voting agency for postal ballot resolutions.

Main board migration

• Board approved migration from BSE SME platform to BSE Main Board and NSE Main Board, subject to approvals.